MADRAC Bulletin - 03/2019 Edition

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

 

 

MADRAC Bulletin - 03/2019 Edition

 

Articles based on Case Report 

▪ Erythropoiesis-stimulating agents: A reminder on the cardiovascular risk in patients with chronic kidney disease

▪ Amiodarone: Risk of acute hepatitis

▪ Levothyroxine: Reminder on the risk of restlessness or irritability

▪ Immunisation anxiety-related reactions

 

What's New?

▪ List of Directives Related to Drug Safety Issues (September - December 2019)


DOWNLOAD Brochure

 


 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 28 May 2020, 08:42:25.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language